Research in the Ackerman group is predominantly focused on the application of molecular engineering tools and quantitative analysis to the development of immunotherapeutics and vaccines.
| Protective Antibodies | Developing tools to parse the humoral immune response to vaccination and infection. Developing a quantitative understanding of antibody functions. |
|---|---|
| Protein engineering for vaccine design | Developing platforms for combinatorial display and in vitro evolution of candidate vaccine immunogens. |
